CNS Pharmaceuticals, Inc.
NASDAQ:CNSP
0.16 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0.006 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.002 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.001 | -0.001 | 0.005 | -0.001 | -0.001 | -0.001 | -0.002 | -0.003 | -0.003 | -0.003 | -0.003 | -0.003 | -0.003 | -0.003 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0.85 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 1.117 | 2.43 | 4.272 | 3.411 | 2.846 | 3.568 | 3.349 | 2.208 | 2.221 | 1.521 | 1.897 | 2.578 | 2.665 | 2.207 | 1.914 | 1.042 | 1.492 | 0.613 | 1.484 | 0.279 | 0.043 | 0.048 | 0 | 0.005 | 0 | 0.016 |
| General & Administrative Expenses
| 1.412 | 1.114 | 1.108 | 1.123 | 1.18 | 1.359 | 2.153 | 1.211 | 1.343 | 1.26 | 0.896 | 1.235 | 1.146 | 1.403 | 1.088 | 0.969 | 0.981 | 1.355 | 1.039 | 0.42 | 0.372 | 0.147 | 0.209 | 0.165 | 0.196 | 0.291 |
| Selling & Marketing Expenses
| -0.001 | -0.001 | -0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 1.411 | 1.114 | 1.107 | 1.123 | 1.18 | 1.359 | 2.153 | 1.211 | 1.343 | 1.26 | 0.896 | 1.235 | 1.146 | 1.403 | 1.088 | 0.969 | 0.981 | 1.355 | 1.039 | 0.42 | 0.372 | 0.147 | 0.209 | 0.165 | 0.196 | 0.291 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 4.681 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.009 | 0 | -0.009 | 0 | -6.409 | 0 | -0.054 | 0 |
| Operating Expenses
| 2.527 | 3.544 | 5.378 | 4.534 | 4.025 | 4.927 | 5.502 | 3.419 | 3.564 | 2.782 | 2.793 | 3.813 | 3.811 | 3.61 | 3.002 | 2.011 | 2.474 | 1.968 | 2.524 | 0.699 | 0.415 | 0.195 | 0.209 | 0.17 | 0.197 | 0.307 |
| Operating Income
| -2.528 | -3.545 | -5.379 | -4.534 | -4.025 | -4.927 | -5.502 | -3.419 | -3.564 | -2.782 | -2.793 | -3.813 | -3.811 | -3.61 | -3.002 | -2.011 | -2.474 | -1.968 | -2.524 | -0.699 | -0.415 | -0.195 | -0.209 | -0.17 | -0.197 | -0.307 |
| Operating Income Ratio
| 0 | 0 | -845.547 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -0.003 | 0 | 0.004 | 0.011 | 0.004 | -0.005 | -0.002 | -0.001 | -0.002 | -0.003 | -0.002 | -0.001 | -0.002 | -0.004 | -0.003 | 0 | 0 | 0 | -0.004 | -0.008 | -0.009 | -0.016 | -6.409 | -0.023 | -0.054 | -0.003 |
| Income Before Tax
| -2.531 | -3.545 | -5.375 | -4.523 | -4.021 | -4.932 | -5.504 | -3.42 | -3.566 | -2.784 | -2.795 | -3.814 | -3.814 | -3.613 | -3.005 | -2.011 | -2.474 | -1.968 | -2.527 | -0.707 | -0.432 | -0.212 | -6.632 | -0.193 | -0.257 | -0.31 |
| Income Before Tax Ratio
| 0 | 0 | -844.899 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -0 | 0 | -0 | 0.013 | 0.008 | 0.011 | 0.002 | 0.001 | 0 | 0.003 | 0.002 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.001 | 0 | 0.007 | -0.195 | 0.014 | -0.17 | 0.006 | -0.003 |
| Net Income
| -2.531 | -3.545 | -5.375 | -4.523 | -4.021 | -4.932 | -5.137 | -3.42 | -3.566 | -3.152 | -3.254 | -3.814 | -3.814 | -3.613 | -3.005 | -2.011 | -2.474 | -1.968 | -2.527 | -0.707 | -0.432 | -0.212 | -6.632 | -0.193 | -0.257 | -0.31 |
| Net Income Ratio
| 0 | 0 | -844.899 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -6.72 | -20.61 | -53.22 | -54.14 | -51.86 | -129.35 | -173.09 | -131.52 | -2.67 | -2.15 | -3.18 | -4.17 | -4.5 | -4.4 | -5.42 | -3.66 | -4.51 | -3.59 | -5.03 | -1.56 | -0.98 | -0.47 | -12.66 | -0.43 | -0.49 | -0.9 |
| EPS Diluted
| -6.72 | -20.34 | -52.84 | -54.14 | -51.86 | -129.35 | -173.09 | -128.13 | -2.67 | -2.15 | -3.18 | -4.17 | -4.5 | -4.4 | -5.42 | -3.66 | -4.51 | -3.59 | -5.03 | -1.56 | -0.98 | -0.47 | -12.66 | -0.43 | -0.49 | -0.89 |
| EBITDA
| -2.527 | -3.544 | -5.378 | -4.52 | -4.017 | -4.925 | -5.5 | -3.416 | -3.561 | -2.778 | -2.789 | -3.81 | -3.808 | -3.607 | -2.998 | -2.008 | -2.471 | -1.966 | -2.524 | -0.698 | -0.415 | -0.195 | -6.618 | -0.17 | -0.251 | -0.003 |
| EBITDA Ratio
| 0 | 0 | -845.398 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |